TeamBest Global Calls for Stronger Collaboration with AROI to Advance Affordable Cancer and Vascular Disease Care in India and Worldwide
Dr. Krishnan Suthanthiran, along with his TeamBest Global family of companies—widely recognized for pioneering cost-effective medical technologies for the diagnosis and treatment of cancer, cardiovascular, and vascular diseases—has released an open letter urging closer collaboration with the Association of Radiation Oncologists of India (AROI). The call emphasizes a shared mission: expanding equitable access to modern cancer care, radiation therapy, and theranostics for patients in India and beyond.
Dr. Suthanthiran’s work spans more than five decades in medical innovation, philanthropy, and global healthcare transformation. His vision centers on delivering superior outcomes at significantly lower costs, using an integrated model that unites prevention, early detection, advanced treatment, patient education, and long-term community support.
ISTRO and Foundation-Led Global Efforts
To support this mission, Dr. Suthanthiran established the International Society of Therapeutic Radiology and Oncology (ISTRO) under the Best Cure Foundation (BCF) and the Brachytherapy Research & Educational Foundation (BREF). These organizations are dedicated to advancing education, fostering scientific exchange, and accelerating the adoption of next-generation cancer care technologies.
ISTRO’s long-term goal is to build a global ecosystem of:
- Best Cure Pro-Health Centers
- Best Cure Cancer Centers
- Best Cure Medical Centers
These centers will operate as nonprofit entities, accessible 24 hours a day, seven days a week, and will manufacture, deploy, and support the full spectrum of technologies necessary for advanced medical care. This includes systems for brachytherapy, linear accelerators, imaging, AI-enabled diagnostics, and precision theranostics. The focus remains on affordability without compromising clinical excellence.
Investing in Education, Innovation, and Collaboration
As part of its educational mission, ISTRO and BREF have contributed 100,000 INR and USD $5,000 toward two major medical gatherings:
- AROI 2026 in Kolkata, India
- ACRO Brachytherapy Conference in Medellín, Colombia
These contributions will support ISTRO awards designated for outstanding professionals, researchers, or innovations—selection for which will be made independently by conference organizers. The awards reinforce TeamBest Global’s commitment to recognizing excellence and advancing cost-effective cancer treatment standards worldwide.
The financial support also signals ISTRO’s intention to actively participate in India’s radiation oncology community and collaborate with national leaders to accelerate adoption of accessible, high-impact therapeutic solutions.
A Preventive Healthcare Model with Global Impact
One of the core principles emphasized in the open letter is the urgent global need to move toward a preventive healthcare economy rather than one dominated by treatment-only strategies.
Dr. Suthanthiran highlights that proactive primary care—including early screening, dental care, eye health, and regular preventive monitoring—combined with access to modern treatment infrastructure, could reduce worldwide mortality from all diseases by as much as 50%. This conclusion aligns with evidence published in The Lancet, which reinforces that structured prevention programs dramatically reduce disease burden and long-term healthcare costs.
TeamBest Global’s Best Cure model operationalizes this philosophy, providing:
- Prevention-focused education
- Early screening and risk assessment
- AI-driven diagnostics
- Precision-based treatment pathways
- Continuous long-term care and follow-up
This integrative approach has the potential to redefine standards of care, especially in developing nations where medical infrastructure gaps limit access to advanced treatment.
Strengthening India’s Leadership in Global Oncology
India plays an increasingly significant role in shaping the global healthcare landscape. With a population of nearly 1.5 billion people and a rapidly growing medical infrastructure, the country is emerging as a hub for healthcare innovation, talent, and service delivery.
Indians trained in India are a critical part of the medical workforce worldwide. In the United States, Indo-American physicians now represent the second-largest group of practicing doctors, contributing significantly across specialties such as oncology, cardiology, internal medicine, and surgery.
This expanding global footprint strengthens India’s position as a leader capable not only of caring for its domestic population but also driving international advancements in cancer and radiation oncology.
Support for India’s Strategic Role in Global Healthcare Diplomacy
During the Quad meeting held in September 2024 in Washington, D.C., former U.S. President Joseph Biden encouraged Prime Minister Narendra Modi to advance India’s position as a global healthcare leader, highlighting cancer care as a key strategic priority. This acknowledgment reflects India’s capacity—not only to innovate—but also to scale solutions that make life-saving treatment available at significantly lower costs than in Western healthcare systems.
In response to these global expectations and aligned with its ongoing mission, the Best Cure Foundation, BREF, and TeamBest Global have announced plans to establish the first two Best Cure Pro Health and Best Cure Medical Centers in India, beginning in 2026. These centers will open in:
- Coimbatore, Tamil Nadu
- Tirupur, Tamil Nadu
The facilities will focus on early diagnosis and comprehensive treatment of cancer, cardiovascular and vascular diseases, diabetes, infectious diseases, neurological disorders, and other major health conditions affecting millions annually.
A Call for Joint Action and Long-Term Partnership
Through this open letter, Dr. Suthanthiran invites the AROI Board of Directors to take a more active role in advancing collaborative research, training programs, treatment standardization, and innovation deployment across India.
The letter encourages AROI leadership to work jointly with:
- ISTRO
- Best Cure Foundation
- Brachytherapy Research & Education Foundation
- TeamBest Global Companies
The objective is not only to support India’s oncology community, but to strengthen global access to high-quality, affordable treatment and ensure every patient—regardless of geography or economic status—has access to the most modern cancer care solutions.
Dr. Suthanthiran and TeamBest Global remain committed to working alongside clinicians, researchers, regulators, and policymakers to build a sustainable healthcare ecosystem driven by innovation, education, compassion, and affordability.
The open letter stands as both an invitation and a challenge—recognizing the tremendous progress made in India while underscoring the work that remains to be done to reduce mortality rates, expand treatment access, and ensure equitable health outcomes. More information about ISTRO and ongoing initiatives can be found at www.istro.net.
Source Link: https://www.businesswire.com/
